Literature DB >> 27352759

Post-Ebola syndrome.

Talha Khan Burki.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27352759     DOI: 10.1016/S1473-3099(15)00259-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  8 in total

1.  Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.

Authors:  Xiankun Zeng; Candace D Blancett; Keith A Koistinen; Christopher W Schellhase; Jeremy J Bearss; Sheli R Radoshitzky; Shelley P Honnold; Taylor B Chance; Travis K Warren; Jeffrey W Froude; Kathleen A Cashman; John M Dye; Sina Bavari; Gustavo Palacios; Jens H Kuhn; Mei G Sun
Journal:  Nat Microbiol       Date:  2017-07-17       Impact factor: 17.745

2.  Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry.

Authors:  Jinwoo Lee; Alex J B Kreutzberger; Laura Odongo; Elizabeth A Nelson; David A Nyenhuis; Volker Kiessling; Binyong Liang; David S Cafiso; Judith M White; Lukas K Tamm
Journal:  Nat Struct Mol Biol       Date:  2021-01-18       Impact factor: 15.369

3.  Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak.

Authors:  Stanislaw P Stawicki; Richard P Sharpe; Sagar C Galwankar; Joan Sweeney; Noel Martins; Thomas J Papadimos; Donald Jeanmonod; Michael S Firstenberg; Lorenzo Paladino; Bhakti Hansoti; Manish Garg
Journal:  J Glob Infect Dis       Date:  2017 Apr-Jun

Review 4.  Recent successes in therapeutics for Ebola virus disease: no time for complacency.

Authors:  Patrick L Iversen; Christopher D Kane; Xiankun Zeng; Rekha G Panchal; Travis K Warren; Sheli R Radoshitzky; Jens H Kuhn; Rajini R Mudhasani; Christopher L Cooper; Amy C Shurtleff; Farooq Nasar; Melek Me Sunay; Allen J Duplantier; Brett P Eaton; Elizabeth E Zumbrun; Sandra L Bixler; Shannon Martin; J Matthew Meinig; Chih-Yuan Chiang; Mariano Sanchez-Lockhart; Gustavo F Palacios; Jeffrey R Kugelman; Karen A Martins; Margaret L Pitt; Ian Crozier; David L Saunders
Journal:  Lancet Infect Dis       Date:  2020-06-18       Impact factor: 25.071

5.  Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol.

Authors:  Louise Sigfrid; Thomas M Drake; Ellen Pauley; Edwin C Jesudason; Piero Olliaro; Wei Shen Lim; Annelies Gillesen; Colin Berry; David J Lowe; Joanne McPeake; Nazir Lone; Daniel Munblit; Muge Cevik; Anna Casey; Peter Bannister; Clark D Russell; Lynsey Goodwin; Antonia Ho; Lance Turtle; Margaret E O'Hara; Claire Hastie; Chloe Donohue; Rebecca G Spencer; Cara Donegan; Alison Gummery; Janet Harrison; Hayley E Hardwick; Claire E Hastie; Gail Carson; Laura Merson; J Kenneth Baillie; Peter Openshaw; Ewen M Harrison; Annemarie B Docherty; Malcolm G Semple; Janet T Scott
Journal:  Lancet Reg Health Eur       Date:  2021-08-06

Review 6.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

7.  The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.

Authors:  Samuel C Ficenec; Donald S Grant; Ibrahim Sumah; Foday Alhasan; Mohamed S Yillah; Jenneh Brima; Edwin Konuwa; Michael A Gbakie; Fatima K Kamara; Nell G Bond; Emily J Engel; Jeffrey G Shaffer; William A Fischer; David A Wohl; Susan D Emmett; John S Schieffelin
Journal:  BMC Infect Dis       Date:  2022-07-18       Impact factor: 3.667

8.  Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study.

Authors:  Luc Overholt; David Alain Wohl; William A Fischer; Daniel Westreich; Sam Tozay; Edwina Reeves; Korto Pewu; David Adjasso; David Hoover; Carson Merenbloom; Harrietta Johnson; Gerald Williams; Tonia Conneh; Joseph Diggs; Alexandria Buller; Darrius McMillian; Darrel Hawks; Karine Dube; Jerry Brown
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.